Michael Chetrit (@chetritmichael) 's Twitter Profile
Michael Chetrit

@chetritmichael

Cardiologist. AsistProf McGill,Former Imaging Fellow @ClevelandClinic. Prez, Canadian Society of MRI. Interested in Cardiac Amyloid and Pericardial diseases.

ID: 705220290561892352

calendar_today03-03-2016 02:36:34

2,2K Tweet

1,1K Takipçi

744 Takip Edilen

Michael Chetrit (@chetritmichael) 's Twitter Profile Photo

Feeling blessed 🙌 to have had the privilege of meeting, talking to, and learning from prez elect @EACVI Victoria Delgado at the #CSEcho2025. Outstanding cast at this years conference. 🎩off to the Canadian Society of Echocardiography prez Igal A. Sebag and VP Amer Johri

Feeling blessed 🙌 to have had the privilege of meeting, talking to, and learning from prez elect @EACVI <a href="/VDelgadoGarcia/">Victoria Delgado</a> at the #CSEcho2025. Outstanding cast at this years conference. 🎩off to the <a href="/CSEchoCa/">Canadian Society of Echocardiography</a> prez <a href="/IgalSebag/">Igal A. Sebag</a> and VP <a href="/amerjohri/">Amer Johri</a>
Victoria Delgado (@vdelgadogarcia) 's Twitter Profile Photo

At #CSEcho2025 there is room to resonate but is fully packed!! Kudos to Michael Chetrit and organizers for the successful sessions! Always hot topic debate CMR vs #echofirst for mitral regurgitation- Amit Patel vs L. Rudski 🤯volume overloaded room👏👏EACVI President

At #CSEcho2025 there is room to resonate but is fully packed!! Kudos to <a href="/ChetritMichael/">Michael Chetrit</a> and organizers for the successful sessions! Always hot topic debate <a href="/whyCMR/">CMR</a> vs #echofirst for mitral regurgitation- Amit Patel vs L. Rudski 🤯volume overloaded room👏👏<a href="/EACVIPresident/">EACVI President</a>
Sanela Music (@music_sanela) 's Twitter Profile Photo

Standing room only at #CSCMR inaugural session within #CSEcho2025: #echofirst vs #whyCMR for MR assessment ft. Dr. A.Patel 🇺🇸 vs Dr. L.Rudski 🇨🇦. Congrats Michael Chetrit for the amazing turnout! Canadian Society of Echocardiography Society for Cardiovascular Magnetic Resonance

Standing room only at #CSCMR inaugural session within #CSEcho2025: #echofirst vs #whyCMR for MR assessment ft. Dr. A.Patel 🇺🇸 vs Dr. L.Rudski 🇨🇦. Congrats <a href="/ChetritMichael/">Michael Chetrit</a> for the amazing turnout! <a href="/CSEchoCa/">Canadian Society of Echocardiography</a> <a href="/SCMRorg/">Society for Cardiovascular Magnetic Resonance</a>
Sharon Mulvagh MD FRCPC FASE FACC (@heartdocsharon) 's Twitter Profile Photo

Another incredible Canadian Society of Echocardiography Hybrid Echo Weekend is in the books! We had almost 1000 registrants, half joining in person, and half virtually! Mark your calendars now for next year"s premiere 🇨🇦Echo meeting #CSEcho2026 as we head to the west coast! Join us in #Vancouver

McGill Cardiology (@cardio_mcgill) 's Twitter Profile Photo

Proud of our cardiology residents representing McGill at #CSEcho2025! Congrats on your excellent presentations and posters! Also wonderful to see so many McGill alumni reunited! Canadian Society of Echocardiography McGill University #echofirst

Proud of our cardiology residents representing McGill at #CSEcho2025!
Congrats on your excellent presentations and posters!
Also wonderful to see so many McGill alumni reunited! 
<a href="/CSEchoCa/">Canadian Society of Echocardiography</a> <a href="/mcgillu/">McGill University</a> #echofirst
JACC Journals (@jaccjournals) 's Twitter Profile Photo

In a cohort of 2,853 pts w/ #Takotsubo syndrome (TTS) enrolled in the GEIST registry, propensity score matching showed beta-blocker therapy is associated w/ lower follow-up mortality, but not w/ lower TTS recurrence. jacc.org/doi/10.1016/j.… #betablockers #JACCHF Sergio Raposeiras-Roubín

In a cohort of 2,853 pts w/ #Takotsubo syndrome (TTS) enrolled in the GEIST registry, propensity score matching showed beta-blocker therapy is associated w/ lower follow-up mortality, but not w/ lower TTS recurrence. jacc.org/doi/10.1016/j.…

#betablockers #JACCHF <a href="/S_Raposeiras/">Sergio Raposeiras-Roubín</a>
Tess Calcagno MD, PharmD (@calcagnotess) 's Twitter Profile Photo

🔥 Just published in @EHJCaseReports: Triathlon training continued triggering pericarditis. Biologics brought relief when standard meds failed. A reminder: exercise isn’t always heart-healthy. 📄 academic.oup.com/ehjcr/advance-… Allan L. Klein Cleveland Clinic Heart, Vascular & Thoracic Cleveland Clinic IM

Edgardo Alania (@ed_alania) 's Twitter Profile Photo

🔴 Early Increase in Serum TTR by Acoramidis Independently Predicts Improved Survival in TTR Amyloid Cardiomyopathy JACC Journals #Cardiology #CardioEd #Amyloidosis

🔴 Early Increase in Serum TTR by Acoramidis Independently Predicts Improved Survival in TTR Amyloid Cardiomyopathy <a href="/JACCJournals/">JACC Journals</a> #Cardiology #CardioEd #Amyloidosis
EHJ Editor-in-Chief (@ehj_ed) 's Twitter Profile Photo

Age-specific troponin thresholds: considerations for the fifth universal definition of myocardial infarction in EHJ. doi.org/10.1093/eurhea… @ESCardio European Society of Cardiology Journals #age #5UDMI John William McEvoy

Age-specific troponin thresholds: considerations for the fifth universal definition of myocardial infarction in EHJ.
doi.org/10.1093/eurhea…
@ESCardio <a href="/ESC_Journals/">European Society of Cardiology Journals</a> #age #5UDMI <a href="/johnwmcevoy/">John William McEvoy</a>
Alex (@ivandemigoal) 's Twitter Profile Photo

Someone posted this video on TikTok of Ivan practicing at Complex Bell on May 19th 👀 Lock in that Calder trophy now folks.

Ronald Witteles (@ron_witteles) 's Twitter Profile Photo

(1/4)Disappointing - if not surprising - news on the AL #amyloidosis space, with the failure of birtamimab to change outcomes in advanced AL amyloidosis. 🙁Thoughts below…

Ahmad Masri (@masriahmadmd) 's Twitter Profile Photo

Excellent study in JACC Journals focusing on I-124 evuzamitide in patients with "early" transthyretin amyloidosis ( having negative or quivocal bone scintigraphy (PYP)). Excellent performance of evuzamitide in this cohort. jacc.org/doi/10.1016/j.… #CardioTwitter

Excellent study in <a href="/JACCJournals/">JACC Journals</a> focusing on I-124 evuzamitide in patients with "early" transthyretin amyloidosis ( having negative or quivocal bone scintigraphy (PYP)). Excellent performance of evuzamitide in this cohort. 

jacc.org/doi/10.1016/j.…

#CardioTwitter
Ronald Witteles (@ron_witteles) 's Twitter Profile Photo

Excited to have participated in this #Delphi study for the management of 🫀#sarcoidosis, just published in JACC Journals. Covers lots of controversial topics in #sarcoid management. sciencedirect.com/science/articl…

Excited to have participated in this #Delphi study for the management of 🫀#sarcoidosis, just published in <a href="/JACCJournals/">JACC Journals</a>. Covers lots of controversial topics in #sarcoid management. sciencedirect.com/science/articl…